Citations 1
S38 On-Body Injector Administration of Risankizumab for Treatment of Moderate-to-Severe Crohn’s Disease: Data From the Fortify Open-Label Longitudinal Real-Life Handling Substudy
Griffith, Jenny, Neimark, Ezequiel, Song, Alexandra , Wallace, Kori, Nannapaneni, Sujani, Zhou, Ji, Andresen, Rachel, Kligys, Kristina, Liao, Xiaomei, Dubinsky, Marla C. , Loftus, Edward V.
American Journal of Gastroenterology | December 5, 2022 | Volume: 117 | Issue: 12S | Pages: S10-S10
